BrainsWay Ltd.
BrainsWay Ltd. Fundamental Analysis
BrainsWay Ltd. (BRSYF) shows moderate financial fundamentals with a PE ratio of 80.89, profit margin of 14.62%, and ROE of 11.10%. The company generates $0.1B in annual revenue with strong year-over-year growth of 37.83%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 71.7/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze BRSYF's fundamental strength across five key dimensions:
Efficiency Score
WeakBRSYF struggles to generate sufficient returns from assets.
Valuation Score
ModerateBRSYF shows balanced valuation metrics.
Growth Score
ModerateBRSYF shows steady but slowing expansion.
Financial Health Score
ExcellentBRSYF maintains a strong and stable balance sheet.
Profitability Score
WeakBRSYF struggles to sustain strong margins.
Key Financial Metrics
Is BRSYF Expensive or Cheap?
P/E Ratio
BRSYF trades at 80.89 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, BRSYF's PEG of 0.60 indicates potential undervaluation.
Price to Book
The market values BrainsWay Ltd. at 8.43 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 66.53 times EBITDA. This signals the market has high growth expectations.
How Well Does BRSYF Make Money?
Net Profit Margin
For every $100 in sales, BrainsWay Ltd. keeps $14.62 as profit after all expenses.
Operating Margin
Core operations generate 8.28 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $11.10 in profit for every $100 of shareholder equity.
ROA
BrainsWay Ltd. generates $6.76 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
BrainsWay Ltd. generates strong operating cash flow of $19.68M, reflecting robust business health.
Free Cash Flow
BrainsWay Ltd. generates strong free cash flow of $16.39M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $0.41 in free cash annually.
FCF Yield
BRSYF converts 2.23% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
80.89
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.60
vs 25 benchmark
P/B Ratio
Price to book value ratio
8.43
vs 25 benchmark
P/S Ratio
Price to sales ratio
12.91
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.09
vs 25 benchmark
Current Ratio
Current assets to current liabilities
3.83
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.11
vs 25 benchmark
ROA
Return on assets percentage
0.07
vs 25 benchmark
ROCE
Return on capital employed
0.05
vs 25 benchmark
How BRSYF Stacks Against Its Sector Peers
| Metric | BRSYF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 80.89 | 29.24 | Worse (Expensive) |
| ROE | 11.10% | 713.00% | Weak |
| Net Margin | 14.62% | -42604.00% (disorted) | Strong |
| Debt/Equity | 0.09 | 0.46 | Strong (Low Leverage) |
| Current Ratio | 3.83 | 4.36 | Strong Liquidity |
| ROA | 6.76% | -16668.00% (disorted) | Weak |
BRSYF outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews BrainsWay Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
50.67%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
190.20%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
898.53%
Industry Style: Defensive, Growth, Innovation
High Growth